מאמרים מ – PubMed
A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.
Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.
Eur J Cancer. 2018 Jun;96:105-110. doi: 10.1016/j.ejca.2018.03.022. Epub 2018 Apr 24.
PMID: 29698932
Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.
Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.
Eur J Cancer. 2018 May;94:1-5. doi: 10.1016/j.ejca.2018.01.112. Epub 2018 Mar 20.
PMID: 29502035
Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013.
Golan T, Sella T, Margalit O, Amit U, Halpern N, Aderka D, Shacham-Shmueli E, Urban D, Lawrence YR.
J Natl Compr Canc Netw. 2017 Aug;15(8):1022-1027. doi: 10.6004/jnccn.2017.0138.
PMID: 28784864
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
Golan T, Raitses-Gurevich M, Kelley RK, Bocobo AG, Borgida A, Shroff RT, Holter S, Gallinger S, Ahn DH, Aderka D, Apurva J, Bekaii-Saab T, Friedman E, Javle M.
Oncologist. 2017 Jul;22(7):804-810. doi: 10.1634/theoncologist.2016-0415. Epub 2017 May 9. Review.
PMID: 28487467
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D.
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
PMID: 27380959
Resilience and psychosocial adjustment in digestive system cancer.
Gouzman J, Cohen M, Ben-Zur H, Shacham-Shmueli E, Aderka D, Siegelmann-Danieli N, Beny A.
J Clin Psychol Med Settings. 2015 Mar;22(1):1-13. doi: 10.1007/s10880-015-9416-9.
PMID: 25605269
[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin].
Berger Y, Zbar AP, Lebedyev A, Levi Y, Nevler A, Aderka D, Golan T, Purim O, Brenner B, Natur M, Gutman M.
Harefuah. 2014 Jun;153(6):315-9, 368. Hebrew.
PMID: 25095601
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
Golan T, Kanji ZS, Epelbaum R, Devaud N, Dagan E, Holter S, Aderka D, Paluch-Shimon S, Kaufman B, Gershoni-Baruch R, Hedley D, Moore MJ, Friedman E, Gallinger S.
Br J Cancer. 2014 Sep 9;111(6):1132-8. doi: 10.1038/bjc.2014.418. Epub 2014 Jul 29.
PMID: 25072261
[Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue].
Levi Y, Barshack I, Avivi K, Bar-ILan D, Gutman M, Aderka D, Berger R, Yacobi R.
Harefuah. 2013 Jun;152(6):326-9, 369. Hebrew.
PMID: 23885463
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, Glynne-Jones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A.
Ann Oncol. 2012 Oct;23(10):2479-516.
PMID: 23012255
Laparoscopic resection of rectal cancer.
Rosin D, Lebedyev A, Urban D, Aderka D, Zmora O, Khaikin M, Hoffman A, Shabtai M, Ayalon A.
Isr Med Assoc J. 2011 Aug;13(8):459-62.
PMID: 21910368
Alice in Wonderland syndrome in H1N1 influenza: case report.
Augarten A, Aderka D.
Pediatr Emerg Care. 2011 Feb;27(2):120. doi: 10.1097/PEC.0b013e318209af7a.
PMID: 21293218
Response to temozolomide in patients with metastatic colorectal cancer with loss of MGMT expression: a new approach in the era of personalized medicine?
Shacham-Shmueli E, Beny A, Geva R, Blachar A, Figer A, Aderka D.
J Clin Oncol. 2011 Apr 1;29(10):e262-5. doi: 10.1200/JCO.2010.32.0242. Epub 2011 Jan 10. No abstract available.
PMID: 21220612
Cetuximab in metastatic colorectal cancer.
Wolf I, Golan T, Shani A, Aderka D.
Lancet Oncol. 2010 Apr;11(4):313-4; author reply 314. doi: 10.1016/S1470-2045(10)70019-X. No abstract available.
PMID: 20359660
Response to chemotherapy predicts survival following resection of hepatic colo-rectal metastases in patients treated with neoadjuvant therapy.
Small RM, Lubezky N, Shmueli E, Figer A, Aderka D, Nakache R, Klausner JM, Ben-Haim M.
J Surg Oncol. 2009 Feb 1;99(2):93-8. doi: 10.1002/jso.21207.
PMID: 19065637
Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines.
Lev-Ari S, Vexler A, Starr A, Ashkenazy-Voghera M, Greif J, Aderka D, Ben-Yosef R.
Cancer Invest. 2007 Sep;25(6):411-8.
PMID: 17882652
High incidence of fistula formation during bevacizumab treatment in rectal cancer patients.
Wolf I, Urban D, Pfeffer R, Catane R, Aderka D.
Acta Oncol. 2007;46(4):550-3. No abstract available.
PMID: 17497324
Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.
Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, Fenig E, Aderka D, Ben-Yosef R.
Anticancer Res. 2006 Nov-Dec;26(6B):4423-30.
PMID: 17201164
PET/CT detects abdominal wall and port site metastases of colorectal carcinoma.
Goshen E, Davidson T, Aderka D, Zwas ST.
Br J Radiol. 2006 Jul;79(943):572-7.
PMID: 16823061
PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan.
Goshen E, Davidson T, Zwas ST, Aderka D.
Technol Cancer Res Treat. 2006 Feb;5(1):37-43.
PMID: 16417400
כתבות של ד"ר דן אדרקה
